Boston Scientific expects adjusted EPS to range between $2.95 and $2.99 for the full year. That marks a significant rise from ...

Neuros Medical announced today that the first commercial patient in the U.S. successfully received an FDA-approved Altius ...

Philips (NYSE: PHG) announced today that it received FDA 510(k) clearance for the latest UroNav image-guided navigation ...

Elekta announced today that it received FDA 510(k) clearance to expand indications for its Leksell Gamma Knife radiosurgery ...

Imperative Care announced today that it received FDA 510(k) clearance for its novel Zoom 7X catheter for aspiration thrombectomy procedures.

Intuitive has boosted the lower end of its full-year revenue guidance after reporting Street-beating Q2 results.